- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 19, 2026 | 686.08K sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 496.23K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 24.06K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $17.33K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.45M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.03M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $2.56M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $2.57M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $92.7K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $453.16K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $99.54K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $453.16K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $32.41M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $98.22M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$328.98K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $791.77K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $8.79M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $8.89M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $10.36M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $10.54M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.82M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.75M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $42.77M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $108.76M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$134.70 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$135.34 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$134.70 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$135.34 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.65M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.41M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$66.74M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.03M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$66.39M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.45M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $1.17M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $271.89K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $543.15K |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $820.1K |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.71M |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.09M |